U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
108181108181A Combination of Abraxane and Cisplatin in Metastatic Breast CancerCompletedNo Results AvailableMetastatic Breast CancerDrug: Abraxane and Cisplatin combinationhttps://ClinicalTrials.gov/show/NCT01149798
108182108182Estimation Of Effect Of Ketoconazole On Pharmacokinetics Of Crizotinib In Healthy VolunteersCompletedHas ResultsHealthyDrug: crizotinib|Drug: ketoconazole|Drug: crizotinibhttps://ClinicalTrials.gov/show/NCT01149785
108183108183Adjusting to Chronic Conditions Using Education, Support, and SkillsCompletedNo Results AvailableChronic Obstructive Pulmonary Disease|Heart Failure|Anxiety|DepressionBehavioral: Adjusting to Chronic Conditions Using Education, Support, and Skillshttps://ClinicalTrials.gov/show/NCT01149772
108184108184Evaluate Reversal of Pathological Epidermal Phenotype in Severe Atopic Dermatitis (AD) With Suppression of Immune Activation During Cyclosporine A TherapyCompletedNo Results AvailableAtopic Dermatitis|EczemaDrug: Cyclosporine Ahttps://ClinicalTrials.gov/show/NCT01149759
108185108185Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting ConditionsCompletedNo Results AvailableHealthyDrug: Tamsulosin|Drug: Tamsulosinhttps://ClinicalTrials.gov/show/NCT01149746
108186108186Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed ConditionsCompletedHas ResultsHealthyDrug: Tamsulosin|Drug: Tamsulosinhttps://ClinicalTrials.gov/show/NCT01149733
108187108187Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid TumorsCompletedNo Results AvailableSolid TumorsDrug: Tivantinib (ARQ 197) Capsule|Drug: Tivantinib (ARQ 197) Tablet|Drug: Tivantinib (ARQ 197) Capsule D, oralhttps://ClinicalTrials.gov/show/NCT01149720
108188108188Safety, Tolerability, Biomarker and Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative ColitisRecruitingNo Results AvailableLeft-Sided Ulcerative Colitis|ProctosigmoiditisDrug: PUR 0110 Rectal Enema 250 mg|Drug: PUR 0110 Rectal Enema 500 mg|Drug: PUR 0110 Rectal Enema 1000 mg|Drug: Placebo Enemahttps://ClinicalTrials.gov/show/NCT01149707
108189108189A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy VolunteersCompletedNo Results AvailableUlcerative ColitisDrug: PUR 0110 Rectal Enema or Placebo Enema|Drug: PUR 0110 Rectal Enema or Placebo Enema|Drug: PUR 0110 Rectal Enema or Placebo Enema|Drug: PUR 0110 Rectal Enema or Placebo Enemahttps://ClinicalTrials.gov/show/NCT01149694
108190108190Clinical Trial of Aplidin® in Patients With Primary MyelofibrosisCompletedNo Results AvailableMyelofibrosisDrug: APLIDIN (plitidepsin)https://ClinicalTrials.gov/show/NCT01149681
108191108191A Safety and Tolerability Study of PCI-24781 in Subjects With CancerCompletedNo Results AvailableLymphoma|Non-Hodgkin's Lymphoma|Hodgkin Disease|Multiple Myeloma|Leukemia|LymphocyticDrug: PCI-24781https://ClinicalTrials.gov/show/NCT01149668
108192108192Efficacy & Safety Study of Oral Aripiprazole in Adolescents With SchizophreniaCompletedHas ResultsSchizophreniaDrug: Aripiprazole|Drug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT01149655
108193108193Randomised Study of Mucositis Prevention After Radiochemotherapy Treatment for Head and Neck CancerCompletedNo Results AvailableSevere Acute Mucositis|Head and Neck CancerDietary Supplement: Oral Impact|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01149642
108194108194Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of DroxidopaCompletedNo Results AvailableSymptomatic Neurogenic Orthostatic HypotensionDrug: Droxidopa|Drug: Droxidopa|Drug: Droxidopahttps://ClinicalTrials.gov/show/NCT01149629
108195108195Effects of Perioperative Intravenous Dexamethasone on Pain in Out Patient Knee SurgeryCompletedNo Results AvailablePost Operative Pain|Nausea and VomitingDrug: Dexamethasone 8mg iv x1|Drug: placebohttps://ClinicalTrials.gov/show/NCT01149616
108196108196The Destination Therapy Evaluation for Failing Fontan StudyRecruitingNo Results AvailableFailing Fontan Physiology|Failing Fontan|Single-ventricle|Single-ventricle Fontan|Single-ventricle PhysiologyDevice: HeartMate II Ventricular Assist Devicehttps://ClinicalTrials.gov/show/NCT01149603
108197108197Scottish COmputed Tomography of the HEART TrialRecruitingNo Results AvailableAngina Pectoris|Coronary Heart DiseaseProcedure: Computer Tomography Angiographyhttps://ClinicalTrials.gov/show/NCT01149590
108198108198Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia PatientsCompletedNo Results AvailableSchizophrenia|SleepDrug: Olanzapinehttps://ClinicalTrials.gov/show/NCT01149577
108199108199Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature InfantsRecruitingNo Results AvailableExtremely Premature Infants|PDA|Oral Ibuprofen|IV IbuprofenDrug: iv ibuprofen|Drug: oral ibuprofenhttps://ClinicalTrials.gov/show/NCT01149564
108200108200CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar IllnessCompletedNo Results AvailableSchizophrenia|Bipolar Disorderhttps://ClinicalTrials.gov/show/NCT01149551
108201108201Postnatal Choline Supplementation in Children With Prenatal Alcohol ExposureCompletedNo Results AvailableFetal Alcohol Spectrum Disorders|Fetal Alcohol Syndrome|Partial Fetal Alcohol Syndrome|Alcohol Related Neurodevelopmental Disorder|Prenatal Alcohol ExposureDrug: Choline bitartrate|Dietary Supplement: Placebo for choline bitartratehttps://ClinicalTrials.gov/show/NCT01149538
108202108202Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple SclerosisActive, not recruitingNo Results AvailableMultiple SclerosisDrug: L-Carnitine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01149525
108203108203Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity ProgramCompletedNo Results AvailableMorbid Obesityhttps://ClinicalTrials.gov/show/NCT01149512
108204108204Valacyclovir 1000 mg Tablet Under Fasting ConditionsCompletedNo Results AvailableHealthyDrug: Valacyclovir|Drug: Valacyclovirhttps://ClinicalTrials.gov/show/NCT01149499
108205108205Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting ConditionsCompletedHas ResultsHealthyDrug: Losartan potassium/Hydrochlorothiazide|Drug: Hyzaar®https://ClinicalTrials.gov/show/NCT01149486
108206108206Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting ConditionsCompletedHas ResultsHealthyDrug: Losartan potassium/Hydrochlorothiazide|Drug: Losartan potassium/Hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT01149473
108207108207Valacyclovir 1000 mg Tablet Under Fed ConditionsCompletedHas ResultsHealthyDrug: Valacyclovir|Drug: Valacyclovirhttps://ClinicalTrials.gov/show/NCT01149460
108208108208Prospective Clinical Follow-up After the Percutaneous Closure of a Patent Foramen OvaleRecruitingNo Results AvailableStroke|Foramen Ovale, Patenthttps://ClinicalTrials.gov/show/NCT01149447
108209108209Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon CancersTerminatedHas ResultsCancer|Neuroendocrine|Ovarian Cancer|Colon CancerDrug: JI-101|Drug: Everolimushttps://ClinicalTrials.gov/show/NCT01149434
108210108210A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesCompletedHas ResultsDiabetes Mellitus, Type 2Drug: LY2189265|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01149421

* Görseller ve İçerik tekif hakkına sahip olabilir